Related references
Note: Only part of the references are listed.Histone Deacetylase Inhibition Enhances Tissue Plasminogen Activator Release Capacity in Atherosclerotic Man
Kristina Svennerholm et al.
PLOS ONE (2015)
Plasmin-dependent modulation of the blood brain barrier: a major consideration during tPA-induced thrombolysis?
Be'eri Niego et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2014)
Histone Deacetylase Inhibitor Treatment Increases Coronary t-PA Release in a Porcine Ischemia Model
Kristina Svennerholm et al.
PLOS ONE (2014)
Is Sodium Valproate, an HDAC inhibitor, associated with reduced risk of stroke and myocardial infarction? A nested case-control study
Alex Dregan et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2014)
Profibrinolytic Effect of the Epigenetic Modifier Valproic Acid in Man
Ott Saluveer et al.
PLOS ONE (2014)
The CXCR1/2 ligand NAP-2 promotes directed intravascular leukocyte migration through platelet thrombi
Mehran Ghasemzadeh et al.
BLOOD (2013)
Histone deacetylase inhibitors stimulate tissue-type plasminogen activator production in vascular endothelial cells
Pia Larsson et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2013)
Valproic acid-associated low fibrinogen and delayed intracranial hemorrhage: case report and mini literature review
Hai-Fei Chen et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2013)
Role of Histone Acetylation in the Stimulatory Effect of Valproic Acid on Vascular Endothelial Tissue-Type Plasminogen Activator Expression
Pia Larsson et al.
PLOS ONE (2012)
Deciphering the molecular and biologic processes that mediate histone deacetylase inhibitor-induced thrombocytopenia
Mark J. Bishton et al.
BLOOD (2011)
Epigenetic control of tissue-type plasminogen activator synthesis in human endothelial cells
Sylvie Dunoyer-Geindre et al.
CARDIOVASCULAR RESEARCH (2011)
Valproic acid attenuates blood-brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 inhibition
Zhifei Wang et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2011)
Mechanisms underlying FeCl3-induced arterial thrombosis
A. Eckly et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Compartment- and context-specific changes in tissue-type plasminogen activator (tPA) activity following brain injury and pharmacological stimulation
Maithili Sashindranath et al.
LABORATORY INVESTIGATION (2011)
Valproate attenuates the risk of myocardial infarction in patients with epilepsy: a nationwide cohort study
Jonas Bjerring Olesen et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2011)
A revised model for the secretion of tPA and cytokines from cultured endothelial cells
Laura Knipe et al.
BLOOD (2010)
Neuroprotection by Valproic Acid in Mouse Models of Permanent and Transient Focal Cerebral Ischemia
Yong Ri Qian et al.
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY (2010)
Impaired myocardial t-PA release in patients with coronary artery disease
B. Osterlund et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2008)
High incidence of vaproate-induced coagulation disorders in children receiving valproic acid: a prospective study
Stephan Koenig et al.
BLOOD COAGULATION & FIBRINOLYSIS (2008)
Valproate-induced thrombocytopenia: A prospective monotherapy study
Wassim Nasreddine et al.
EPILEPSIA (2008)
Common genetic variation in five thrombosis genes and relations to plasma hemostatic protein level and cardiovascular disease risk
Sekar Kathiresan et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Impaired capacity for stimulated fibrinolysis in primary hypertension is restored by antihypertensive therapy
W Ridderstråle et al.
HYPERTENSION (2006)
Tissue-type plasminogen activator: A multifaceted modulator of neurotransmission and synaptic plasticity
Andre L. Samson et al.
NEURON (2006)
Endothelial t-PA release is impaired in overweight and obese adults but can be improved with regular aerobic exercise
GP Van Guilder et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Impaired endothelial release of tissue-type plasminogen activator in patients with chronic kidney disease and hypertension
T Hrafnkelsdóttir et al.
HYPERTENSION (2004)
An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability
L Tremolizzo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Tissue-type plasminogen activator (t-PA) is stored in Weibel-Palade bodies in human endothelial cells both in vitro and in vivo
D Huber et al.
BLOOD (2002)
Share Paper
